Cholesteatoma, Middle Ear Clinical Trial
Official title:
Evaluation of the Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma
Verified date | September 2020 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | October 1, 2022 |
Est. primary completion date | October 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All adults above the age of 18 presented to the Assiut university Clinic with cholesteatoma will be included in the study. Exclusion Criteria: 1. Patients with previous mastoid surgery 2. Patients with Craniofacial anomalies or cleft lip and palate 3. Pediatric populations = 18 years old 4. Patients with congenital ear anomalies |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the Level of Middle Cranial Fossa Dura in Patients with Cholesteatoma by multislice computed tomography. | determination the level of tegmen in patients with attico-antral diseases by MSCT | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06246682 -
Impact of Mastoid Condition on Results of Endoscopic Management of Cholesteatoma
|
N/A | |
Completed |
NCT02554422 -
Objective Measurement of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively
|
N/A |